The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.
https://doi.org/10.14341/osteo2011137-37
About the Authors
D BlackI. R. Reid
J. A. Cauley
S Boonen
F Cosman
P C Leung
P Lakatos
Z Man
S. R. Cummings
T. F. Hue
M. E. Ruzycky
R Martinez
G Su
C Bucci-Rechtweg
R Eastell
Review
For citations:
Black D., Reid I.R., Cauley J.A., Boonen S., Cosman F., Leung P.C., Lakatos P., Man Z., Cummings S.R., Hue T.F., Ruzycky M.E., Martinez R., Su G., Bucci-Rechtweg C., Eastell R. The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft. Osteoporosis and Bone Diseases. 2011;14(1):37-37. (In Russ.) https://doi.org/10.14341/osteo2011137-37
Views:
685
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
